黄京《自然》文章首次发现p53新机制

　　

生物通报道：来自美国宾州Wistar研究院（The Wistar Institute）基因表达和调控研究小组，和奥地利维也纳生物中心（The Vienna Biocenter）分子病理学研究院（Research Institute of Molecular Pathology，IMP)的研究人员发现了一种与p53蛋白的正常抑癌功能相关的新机制：一种新发现的酶——Smyd2能在肌体不再需要p53蛋白发挥作用时能够抑制p53蛋白的活性。这是第二次发现甲基化能调节p53蛋白活性，有趣的是第一次有关甲基化调节p53蛋白活性研究的结果与这一次的结果正好相反。这一研究成果公布在11月30日出版的《Nature》杂志上。

这一研究报告的第一作者是来自Wistar研究院的黄京（Jing Huang，音译）。

原文摘要：
Nature 444, 629-632 (30 November 2006) | doi:10.1038/nature05287; Received 21 July 2006; Accepted 22 September 2006; Published online 15 November 2006
Repression of p53 activity by Smyd2-mediated methylation
[Abstract]

p53基因是一种肿瘤抑制基因，定位于人类17号染色体短臂，编码p53磷蛋白；p53磷蛋白的正常功能是调控细胞增殖，在白血病、骨肉瘤、肺癌和结直肠癌中有p53蛋白的突变和缺失。现在已经证明，p53蛋白是人体内最有效的对抗肿瘤的自然防御物。最近关于p53最重要的发现是：一些小分子药物可以通过阻止p53负调节子Mdm2与p53的结合来激活p53。这一研究为新的肿瘤治疗方法、通过蛋白质相互作用找到新的、有效的药物靶点提供了光明的前景，因此p53多年以来一直是肿瘤研究的热点领域。

另一方面，组蛋白赖氨酸甲基化特异性位点是调控转录激活或抑制的一个重要因素，目前所知p53是由赖氨酸甲基化调控的少见的非组蛋白之一，在这篇文章中，研究人员发现Smyd2这种赖氨酸转甲基酶可以使p53蛋白上的Lys370位点甲基化——这是从来未发现过的甲基化位点。

这对于肿瘤研究意义重大，正如Wistar  研究所Hilary  Koprowski教授说的那样：“我们所关心的是这些酶过表达、过活化，就有可能抑制p53蛋白正常的肿瘤抑制功能，进而引发癌症。如果真是这样，我们就可以设计一种药物，抑制此酶的活性，释放p53蛋白让它去完成抑制肿瘤的工作。此酶表达水平过高，也许可以成为一种癌症诊断标志。”

这项研究中发现Smyd2向p53蛋白的特异位点添加一个甲基基团，导致p53蛋白不能与DNA结合而发挥作用，这也就是说Smyd2作用位点的甲基化能够抑制p53蛋白与DNA结合，解释了为什么甲基化是一种抑制修饰。

这一新机制能够在p53蛋白存在的条件下关闭p53蛋白的活性，在DNA受损时及时恢复p53蛋白的活性。这对于细胞而言意义重大，因为如果p53蛋白始终存在，随时准备与DNA结合，那么细胞就不能分裂，它们会死亡。

在之前发现的另一个甲基化调节p53蛋白活性的研究中，研究人员向p53蛋白K372位点添加甲基化基团，发现p53蛋白的肿瘤抑制活性不但没有下降，反而上升了（这与Smyd2作用位点甲基化效果恰恰相反），K372位点目前正在研究过程中。K372与目前这一Smyd2研究发现的位点接近，更多实验也发现这两个位点相互作用紧密。黄京表示：“如果先前报道的位点已经被甲基化了，那么我们发现的位点就不能再被甲基化，反之亦然。”
（生物通：万纹）

附：
p53相关文章

• Turning the key on p53
  
• Siah-1b is a direct transcriptional target of p53
  
• Inhibition of Human p53 Basal Transcription by Down-regulation of Protein Kinase C
  
• Identification of p53 regulators by genome-wide functional analysis
  
• Apoptosis from Signaling Pathways to Therapeutic Tools-16-ca-Assessment of In Vivo Chemotherapy-Induced DNA Damage in a p53-Mutated Rat Tumor by Micronuclei Assay

• in the Cytoplasm
  
• MDM2-p53-Independent Functions of MDM2
  
• Monitoring p53's pulse
  
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
  
• Dynamics of the p53-Mdm2 feedback loop in individual cells
  
• Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53
  
• On the excess of G?úT transversions in the p53 gene in lung cancer cell lines
  
• Invariant p53 immunostaining in primary and recurrent breast cancer
  
• Conquering the complexity of p53
  
• Acute Ablation of Survivin Uncovers p53-dependent Mitotic Checkpoint Functions and Control of Mitochondrial Apoptosis
  
• Cdk2-dependent Phosphorylation of the NF-Y Transcription Factor and Its Involvement in the p53-p21 Signaling
  
• Gene Therapy For Killing P53-Negative Cancer Cells
  
• Induction of p53-dependent Activation of the Human Proliferating Cell Nuclear Antigen Gene in Chromatin
  
• Ubiquitin-Pirh2,-P53-Induced Ubiquitin-Protein Ligase, Promotes P53 Degradation
  
• There?ˉs No Business Like P53 Business-In Chronic Inflammatory Disease
  
• The Prolyl Isomerase Pin1 Reveals-Mechanism To Control P53 Functions After Genotoxic Insults
  
• The Prolyl Isomerase Pin1 Is-Regulator Of P53 In Genotoxic Response
  
• Redefining P53-Entering The Tumor Suppressor Era
  
• P53 Kingdom,-New Prospect Of Its Control Mechanism And Apoptotic Defense
  
• Myc Suppression Of The P21cip1 Cdk Inhibitor Influences The Outcome Of The P53 Response To Dna Damage
  
• Geminin And P53-Deterrents To Re-Replication In Human Cancer Cells
  
• Akt Inhibits Dna Damage By Suppressing P73, P53, Forkhead Or All Three
  
• Guardian Of-Genome's Guardian
  
• And Drug-Induced Apoptotic Responses Mediated By Bh3-Only Proteins Puma And Noxa
  
• An Internal Investigation
  
• Decision Making By P53-Life, Death And Cancer
  
• Bax And Bh3-Domain-Only Proteins In P53-Mediated Apoptosis
  
• TP53INP1s and Homeodomain-interacting Protein Kinase-2 (HIPK2) Are Partners in Regulating p53 Activity
  
• The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability
  
• The Phosphatase MKP1 Is a Transcriptional Target of p53 Involved in Cell Cycle Regulation
  
• Synuclein Displays an Antiapoptotic p53-dependent Phenotype and Protects Neurons from 6-Hydroxydopamine
  
• Phosphorylation Site Interdependence of Human p53 Post-translational Modifications in Response to Stress
  
• Integration of interferon signalling to p53 responses in tumour suppression and antiviral defence
  
• HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
  
• Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
  
• Cell Type-and Promoter-specific Roles of Ser18 Phosphorylation in Regulating p53 Responses
  
• Base Excision Repair Intermediates Induce p53-independent Cytotoxic and Genotoxic Responses
  
• Ataxia Telangiectasia-mutated Protein Can Regulate p53 and Neuronal Death Independent of Chk2
  
• Activation of p53 by Oxidative Stress Involves Platelet-derived Growth Factor-Receptor-mediated Ataxia
  
• A stabilizing influence
  
• A p53-independent G1 Cell Cycle Checkpoint Induced by the Suppression of Protein Kinase C and Isoforms
  
• Identification and Characterization of the Cytoplasmic Protein TRAF4 as a p53-regulated Proapoptotic Gene
  
• An Old Dog Begins To Learn New Tricks
  
• Opposite Role of Yeast ING Family Members in p53-dependent Transcriptional Activation
  
• Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes
  
• Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes

• Bcl-2 Controls Caspase Activation Following a p53-dependent Cyclin D1-induced Death Signal
  
• Anti-p53-directed immunotherapy
  
• Mdm2 module and the ubiquitin system
  
• Adenovirus-Mediated mda-7 Gene Expression Radiosensitizes Non-Small Cell Lung Cancer Cells via TP53-Independent Mechanisms
  
• The p53-Mdm2 module and the ubiquitin system
  
• Activated protein C blocks p53-mediated apoptosis in ischemic brain endothelium-neuroprotective
  
• p53RDL1 regulates p53-dependent apoptosis
  
• INHIBITING THE P53-MDM2 INTERACTION-AN IMPORTANT TARGET FOR CANCER THERAPY
  
• Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner
  
• Cell signaling, transcription and translation as therapeutic targets-Regulation of p53-intricate loops and delicate balances
  
• Suppression of mismatched mutation by p53-a mechanism for guarding genomic integrity
  
• Proliferation-dependent induction of apoptosis by the retinoid CD437 in p53-mutated keratinocytes
  
• Good Cop-Bad Cop
  
• BAX and BH3-domain-only proteins in p53-mediated apoptosis
  
• DNA-p53-An Internal Investigation
  
• p53-An Internal Investigation
  
• p63 and p73 are required for p53-dependent apoptosis in response to DNA damage
  
• specific mutations in p53-The acid test
  
• Nuclear structure and cancer-Mutant p53-gain of function through perturbation of nuclear structure and function
  
• The p53-p63-p73 family of transcription factors-overlapping and distinct functions
  
• Breakthroughs and Views-p53-Induced Apoptosis as a Safeguard against Cancer
  
• Regulation of p53 localization
  
• Regulation of cellular senescence by p53
  
• Post-translational modifications and activation of p53 by genotoxic stresses
  
• p300-CBP-p53 interaction and regulation of the p53 response
  
• Modulation of p53 function in cellular regulation
  
• p53- Death Star
  
• p53-lung cancer
  
• same family different rules
  
• p53 mutagenesis
  
• MDM2-circuit
  
• MDM2 circuit
  
• p53 DNA-repair
  
• p53 DNA repair
  
• p53 development
  
• cancer therapy
  
• p53 2
  
• p53 1
  
• Role of the p53-homologue p73 in E2F1-induced apoptosis
  
• cycle regulation of the p53-inducible gene B99
  
• Histone Deacetylases Specifically Down-regulate p53-dependent Gene Activation
  
• Regulation of angiogenesis in human hepatomas: possible involvement of p53-inducible inhibitor of vascular endothelial cell proliferation
  
• p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53
  
• Maf Transcriptionally Activates the Mouse p53 Promoter and Causes a p53-dependent Cell Death
  
• Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis